ARDT: Ardent Health Partners Inc Price to Sales
Ardent Health Partners, Inc. (ARDT) relies on inelastic demand in emergency medicine and partnerships with universities. The price-to-sales valuation reflects market expectations, with the current value standing at 0.40. Logistic disruptions are indirectly weighing on equipment supplies, while physician wage inflation limits pricing power during negotiations with insurance agents.
Analytical breakdowns for Ardent Health Partners Inc (ARDT)
- stock price and consensus target price:
- market capitalization information:
- shareholders' equity book value data:
- issuer credit burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Ardent Health Partners, Inc.|ARDT - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Ardent Health Corp|ARDT - Company Aggregate Debts|Debts to Book Value Ardent Health Partners Inc|ARDT - Company Long-Term Debts|Company Short-Term Debts Ardent Health Partners|Quick Liquidity ardenthealth.com
- net income and valuation multiples indicators:
ARDT - Net Income|Future Net Profit Ardent Health Partners, Inc.|ARDT - P/E Multiple|Future Price to Earnings Multiple Ardent Health|ARDT - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Ardent Health Partners Inc|ARDT - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Ardent Health Partners|ARDT - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth ardenthealth.com|ARDT - Earnings per share growth in current year|Expected earnings per share trend next year Ardent Health Partners, Inc.
- sales revenue and business income indicators:
General company analysis:ARDT - ardenthealth.com
The P/S ratio is calculated as the ratio of Ardent Health Partners (ARDT) market capitalization to its annual revenue, determining the value of each dollar of sales within the valuation structure. For this clinic network with a steady patient inflow and insurance support, the price-to-sales metric serves as an indicator of business overvaluation relative to the ecosystem's stable cash flows.
Competing companies
hcahealthcare.com - Market Cap to Revenue Ratio|P/S Multiple THC (Tenet Healthcare Corporation)|Fresenius Medical Care AG (FMS) - Price to Sales|SOLV - Price-to-Revenue Ratio|EHC (Encompass) - Market Cap to Revenue Ratio|UHS (uhsinc.com) - Market Cap to Revenue|DVA: Market Cap to Sales Volume|Market Cap to Revenue RDNT|OPCH: Market Capitalization-to-Revenue Ratio|P/S Multiple SGRY|PINC (Premier Health) - Market Capitalization-to-Revenue Ratio|P/S Multiple EYE (National Vision Holdings)|progyny.com (PGNY) - Price to Sales|Select Medical Holdings - P/S Multiple|ASTH - P/S Multiple|Pediatrix Medical Group, Inc. (MD) - Price-to-Revenue Ratio|USPH (U.S. Physical Therapy, Inc.) - Price-to-Revenue Ratio|Market Cap to Revenue PNTG|ORGO (organogenesis.com) - Market Cap to Sales Volume|P/S Multiple NUTX|AUNA (Auna S.A.) - Market Capitalization-to-Revenue Ratio|SBC Medical Group Holdings Inc. - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio EOLS|CYH - Price-to-Revenue Ratio|Price-to-Sales Ratio SKIN|MDWD: P/S Multiple|Biote (BTMD) - P/S Multiple|Price-to-Revenue Ratio The Joint Corporation|DCGO: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue PIII (P3 Health Partners Inc.)|Market Cap to Sales Volume GANX|Price-to-Revenue Ratio EUDA Health Holdings Limited EUDA|BMGL: Market Cap to Revenue Ratio|CollPlant Ltd - P/S Multiple|Price to Sales Cuprina Holdings Limited|Concord Medical Services (CCM) - Price-to-Revenue Ratio|ashs.com - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio MEDIROM Healthcare Group|Avalon GloboCare Corporation (ALBT) - Price-to-Revenue Coefficient|Market Cap to Revenue DHAI (DIH Holding US Inc.)|XAGE (Carmell Corp) - Market Capitalization-to-Revenue Ratio|P/S Multiple NIVF (NewGenIvf Group Limited)|Price-to-Revenue Coefficient ATI Physical Therapy Inc. (ATIP)|CMAX - Price-to-Revenue Ratio|KDLY (Kindly MD Inc) - Market Cap to Revenue Ratio|MODV: P/S Multiple|Market Cap to Revenue Novo Integrated Sciences Corp|Market Cap to Revenue SSY|imacholdings.comm (BACK) - Price-to-Revenue Coefficient
